| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0033 | 1 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |